Literature DB >> 25511644

Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.

Bhawna Sharma1, Kalyan C Nannuru, Michelle L Varney, Rakesh K Singh.   

Abstract

Host-derived angiogenic and inflammatory tumor supportive microenvironment regulates progression and metastasis, but the molecular mechanism(s) underlying host-tumor interactions remains unclear. Tumor expression of CXCR2 and its ligands have been shown to regulate angiogenesis, invasion, tumor growth, and metastasis. In this report, we hypothesized that host-derived Cxcr2-dependent signaling plays an important role in breast cancer growth and metastasis. Two mammary tumor cell lines Cl66 and 4T1 cells were orthotopically implanted into the mammary fat pad of wild-type and Cxcr2(-/-) female BALB/c mice. Tumor growth and spontaneous lung metastasis were monitored. Immunohistochemical analyses of the tumor tissues were performed to analyze proliferation, angiogenesis, apoptosis and immune cell infiltration. Our results demonstrated that knock-down of host Cxcr2 decreases tumor growth and metastasis by reducing angiogenesis, proliferation and enhancing apoptosis. Host Cxcr2 plays an important role in governing the pro-inflammatory response in mammary tumors as evaluated by decreased Gr1(+) tumor-associated granulocytes, F4/80(+) tumor associated macrophages, and CD11b(+)Gr1(+) myeloid derived suppressor cells in Cxcr2(-/-) mice as compared to control wild-type mice. Together, these results demonstrate that host Cxcr2-dependent signaling regulates mammary tumor growth and metastasis by promoting angiogenesis and pro-inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25511644      PMCID: PMC4821540          DOI: 10.1007/s10585-014-9691-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  41 in total

Review 1.  Current status of chemokine receptor inhibitors in development.

Authors:  Marcello Allegretti; Maria Candida Cesta; Alexandre Garin; Amanda E I Proudfoot
Journal:  Immunol Lett       Date:  2012-04-20       Impact factor: 3.685

Review 2.  Tumor-associated neutrophils: new targets for cancer therapy.

Authors:  Alyssa D Gregory; A McGarry Houghton
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

Review 3.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Endocr Rev       Date:  2007-04-04       Impact factor: 19.871

4.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

5.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

6.  Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

Authors:  L Kozłowski; I Zakrzewska; P Tokajuk; M Z Wojtukiewicz
Journal:  Rocz Akad Med Bialymst       Date:  2003

7.  Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.

Authors:  Thomas Jamieson; Mairi Clarke; Colin W Steele; Michael S Samuel; Jens Neumann; Andreas Jung; David Huels; Michael F Olson; Sudipto Das; Robert J B Nibbs; Owen J Sansom
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

Review 8.  Cancer CXC chemokine networks and tumour angiogenesis.

Authors:  Robert M Strieter; Marie D Burdick; Javier Mestas; Brigitte Gomperts; Michael P Keane; John A Belperio
Journal:  Eur J Cancer       Date:  2006-02-28       Impact factor: 9.162

9.  Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.

Authors:  Thomas J Wilson; Kalyan C Nannuru; Mitsuru Futakuchi; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

10.  Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.

Authors:  Bhawna Sharma; Rakesh K Singh
Journal:  J Carcinog       Date:  2011-12-22
View more
  23 in total

1.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

2.  CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms.

Authors:  Shira Bernard; Megan Myers; Wei Bin Fang; Brandon Zinda; Curtis Smart; Diana Lambert; An Zou; Fang Fan; Nikki Cheng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-08-09       Impact factor: 2.673

3.  Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.

Authors:  Anastasia R Aikins; MiJung Kim; Bernardo Raymundo; Chan-Wha Kim
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-06

4.  Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Authors:  Charles S Tannenbaum; Patricia A Rayman; Paul G Pavicic; Jin Sub Kim; Wei Wei; Alexandra Polefko; Wesley Wallace; Brian I Rini; Gareth Morris-Stiff; Daniela S Allende; Thomas Hamilton; James H Finke; C Marcela Diaz-Montero
Journal:  Cancer Immunol Res       Date:  2019-08-22       Impact factor: 11.151

5.  Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Sugandha Saxena; Caitlin Molczyk; Abhilasha Purohit; Evie Ehrhorn; Paran Goel; Dipakkumar R Prajapati; Pranita Atri; Sukhwinder Kaur; Paul M Grandgenett; Michael A Hollingsworth; Surinder K Batra; Rakesh K Singh
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 6.  Bladder cancer, inflammageing and microbiomes.

Authors:  Austin Martin; Benjamin L Woolbright; Shahid Umar; Molly A Ingersoll; John A Taylor
Journal:  Nat Rev Urol       Date:  2022-07-07       Impact factor: 16.430

Review 7.  The function of TRP channels in neutrophil granulocytes.

Authors:  Karolina Najder; Boris Musset; Otto Lindemann; Etmar Bulk; Albrecht Schwab; Benedikt Fels
Journal:  Pflugers Arch       Date:  2018-05-01       Impact factor: 3.657

8.  Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice.

Authors:  Xuanmao Jiao; Lifeng Tian; Zhao Zhang; Joanna Balcerek; Andrew V Kossenkov; Mathew C Casimiro; Chenguang Wang; Yichuan Liu; Adam Ertel; Raymond E Soccio; Eric R Chen; Qin Liu; Anthony W Ashton; Wei Tong; Richard G Pestell
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

Review 9.  An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.

Authors:  Amaresh Mishra; Kamrul Hassan Suman; Nisha Nair; Jaseela Majeed; Vishwas Tripathi
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

10.  CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.

Authors:  Asim Pervaiz; Michael Zepp; Saqib Mahmood; Doaa Mohamed Ali; Martin R Berger; Hassan Adwan
Journal:  Cell Oncol (Dordr)       Date:  2018-11-19       Impact factor: 7.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.